Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs Energy Fuels Inc Ordinary Shares (Canada) (UUUU) Price & Performance

Energy Fuels Inc Ordinary Shares (Canada)Trade

Price performance (Past 24H)

Key statistics

Sanofi SA vs Energy Fuels Inc Ordinary Shares (Canada) — how do they compare? Sanofi SA trades at $40.7 (market cap $96.38B), while Energy Fuels Inc Ordinary Shares (Canada) trades at $8.19 (market cap $2.21B). The key difference: Sanofi SA is far larger — about 43.6× Energy Fuels Inc Ordinary Shares (Canada)'s market cap, and Sanofi SA pays a 6.08% dividend while Energy Fuels Inc Ordinary Shares (Canada) pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Energy Fuels Inc Ordinary Shares (Canada) for 0 Days on average.

SNYUUUU
Market Cap
$96.38B$2.21B
Volume
5,335,34215,605,017
Sector
HealthEnergy
52-Week High
$52.34$27.72
52-Week Low
$39.12$8.34
Typical Hold Time
94 Days0 Days
Enterprise Value
$115.67B$1.95B
Dividend Yield
6.08%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sanofi SA

Sanofi (SNY) trades at $39.12, down 1.56% with a bearish technical signal despite recent earnings beats. The company shows solid fundamentals with $46.72B revenue, 16.72% net margin, and reasonable valuation (P/E 21.71). Recent expansion of the Regeneron immunology alliance worth up to $8B signals growth potential beyond Dupixent, though 2026 forecasts indicate profit margin compression to 8.09%.

SNY presents a mixed outlook with strong current execution offset by future margin pressures. The bullish analyst consensus (44% Buy) and expanding immunology pipeline provide upside catalysts, while patent expirations and competitive threats pose medium-term risks. Cash flow volatility and debt levels require monitoring for long-term investors.

Energy Fuels Inc Ordinary Shares (Canada)

Energy Fuels (UUUU) trades at $9.27, down 4.04% amid negative sentiment following a securities fraud investigation announcement. The stock shows weak technical positioning near recent lows with neutral indicators. Fundamentally, the company continues to report significant losses with a -77.3% net income margin despite revenue growth projections, while heavy investment in uranium and rare earth expansion creates substantial cash burn.

While analyst consensus remains bullish with a $21.06 price target representing 127% upside, execution risks are elevated. The securities investigation, persistent losses, and massive capital requirements for growth projects create substantial headwinds. Success depends on the company's ability to fund expansion and achieve profitability in the competitive critical minerals sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SNY
100% Buy0% Sell
Avg holding period · 94 Days
UUUU
69% Buy31% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY →

About Energy Fuels Inc Ordinary Shares (Canada)

Energy Fuels Inc. is a US producer of uranium, vanadium, and rare earth elements. It operates the White Mesa Mill in Utah, the only fully licensed and operating conventional uranium processing facility in the country.

Read more on UUUU →